Ultragenyx Pharmaceutical | Despesas De Vendas E Administração



Selling And Administration Expenses Alterar Data
Acadia Pharmaceuticals USD 130.08M 3.21M 2024-12
Agios Pharmaceuticals USD 41.53M 10.17M 2025-03
Alnylam Pharmaceuticals USD 239.95M 55.39M 2025-03
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
Insmed USD 142.51M 23.58M 2024-12
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
Kyowa Hakko Kirin JPY 42.04B 1.66B 2025-03
MacroGenics USD 27.81M 13.71M 2024-12
Moderna USD 212M 139M 2025-03
Neurocrine Biosciences USD 287.8M 53.5M 2024-12
PTC Therapeutics USD 84.68M 11.23M 2024-12
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03
Sarepta Therapeutics USD 163.87M 35.67M 2024-12
Ultragenyx Pharmaceutical USD 82.49M 2.14M 2024-12
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12



Ultragenyx Pharmaceutical Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.